# Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.

> **NCT00404287** · PHASE4 · TERMINATED · sponsor: **AORTICA Group** · enrollment: 164 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DRUG:** Fluvastatin

## Key facts

- **NCT ID:** NCT00404287
- **Lead sponsor:** AORTICA Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10-01
- **Primary completion:** 2014-11-01
- **Final completion:** 2018-01
- **Target enrollment:** 164 (ACTUAL)
- **Why stopped:** Funding not enough to complete the study
- **Last updated:** 2019-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404287, "Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00404287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*